home
***
CD-ROM
|
disk
|
FTP
|
other
***
search
/
TIME: Almanac 1995
/
TIME Almanac 1995.iso
/
time
/
072991
/
0729351.000
< prev
next >
Wrap
Text File
|
1994-03-25
|
2KB
|
51 lines
<text id=91TT1675>
<title>
July 29, 1991: A Counterfeit Treatment
</title>
<history>
TIME--The Weekly Newsmagazine--1991
July 29, 1991 The World's Sleaziest Bank
</history>
<article>
<source>Time Magazine</source>
<hdr>
MEDICINE, Page 51
A Counterfeit Treatment
</hdr><body>
<p> The drug DDC is one of the few hopes on the dark horizon of
an AIDS patient. Recent studies, including one reported at last
month's International Conference on AIDS in Florence, have
shown that DDC, formally known as dideoxycytidine, can reduce
the activity of the AIDS virus, especially in combination with
the medication AZT. Although Hoffman-La Roche has made the drug
available to 4,000 participants in a research program, many
people remain ineligible because they are on other anti-AIDS
drugs or do not yet have symptoms of the disease. But the major
obstacle is that the drug has yet to be approved by the Food and
Drug Administration.
</p>
<p> Late last week, however, the FDA bucked its own
bureaucratic tradition when one of its advisory committees
recommended that a similar drug made by Bristol-Myers Squibb,
called DDI, or dideoxyinosine, be put on the market even though
it has not undergone the agency's standard testing. While the
decision heartened many AIDS organizations, some desperate
patients have resorted to an immediate alternative: black-market
DDC. Underground AIDS groups are buying the drug in bulk
directly from chemical companies, which manufacture it for use
in laboratory experiments. The clandestine suppliers then weigh
out and package the counterfeit pills and sell them at cost in
what experts say is the first large-scale pirating of a drug
developed by a major firm.
</p>
<p> AIDS patients feel that their bleak situation justifies
the illegal trade. Hoffman-La Roche contends that the
counterfeit pills may contain dangerous contaminants or that
they may be formulated in incorrect, and possibly toxic, doses.
But fear of the disease far outweighs any fear of the drug.
</p>
</body></article>
</text>